Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane D. Englebright currently holds 7,688 shares of HCA Healthcare, Inc. (HCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane D. Englebright has been a net seller of HCA stock. They have purchased $0 and sold $10.0M worth of shares.
Jane D. Englebright's most recent insider trade was on Nov 9, 2021, when they sold 3,364 shares at $249.61 per share.
Jane D. Englebright serves as Executive at HCA Healthcare, Inc. (HCA). They have executed 85 insider transactions totaling $10.0M over their tenure at the company.
Jane D. Englebright holds the position of Executive at HCA Healthcare, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Jane D. Englebright has shown a selling trading pattern, with $0 in total purchases and $10.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jane D. Englebright was on Jul 27, 2021, when they sold $1.2M worth of HCA shares. This transaction involved 4,782 shares at $247.69 per share.
Jane D. Englebright currently owns 7,688 shares of HCA Healthcare, Inc. (HCA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane D. Englebright's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane D. Englebright has 85 Form 4 filings on record as an insider at HCA Healthcare, Inc..
Set alerts for Jane D. Englebright and 40,000+ other insiders.